4- Eppedo 10 Epirubicin HCI 10mg,
Methylparaben 10mg
1
4- Eppedo 10 VIAL
450.00
4- Eppedo 10 from Miracalus contains Epirubicin
Below are some of the details of Epirubicin(generic)
Epirubicin is an anthracycline drug used for chemotherapy. It is marketed by Pfizer under the trade name Ellence in the US and Pharmorubicin or Epirubicin Ebewe elsewhere.
Similarly to other anthracyclines, epirubicin acts by intercalating DNA strands. Intercalation results in complex formation which inhibits DNA and RNA synthesis. It also triggers DNA cleavage by topoisomerase II, resulting in mechanisms that lead to cell death. Binding to cell membranes and plasma proteins may be involved in the compound's cytotoxic effects. Epirubicin also generates free radicals that cause cell and DNA damage.
Epirubicin is favoured over doxorubicin, the most popular anthracycline, in some chemotherapy regimens as it appears to cause fewer side-effects. Epirubicin has a different spatial orientation of the hydroxyl group at the 4' carbon of the sugar, which may account for its faster elimination and reduced toxicity. Epirubicin is primarily used against breast and ovarian cancer, gastric cancer, lung cancer, and lymphomas.
4 Eppedo 50 Epirubicin HCI 50mg,
Methylparaben 10mg
1
4 Eppedo 50 VIAL
2200.00
4-Epeedo Epirubicin 10mg,
Methylparaben 10mg
-
4-Epeedo INJ
450.00
4-Epeedo Epirubicin 50mg,
Methylparaben 10mg
-
4-Epeedo INJ
2000.00
Alrubicin 10mg
1
Alrubicin VIAL
522.00
Alrubicin 50mg
1
Alrubicin VIAL
2012.40
Epidox 10mg
1
Epidox VIAL
500.00
Epidox 50mg
1
Epidox VIAL
2290.00
Epithra 10mg
1
Epithra VIAL
403.20
Epithra 50mg
1
Epithra VIAL
2073.20
Epithra 100mg
1
Epithra VIAL
3906.00
Epricin 10mg
1
Epricin VIAL
380.00
Epricin 50mg
1
Epricin VIAL
1900.00
Rubilon 10mg
1
Rubilon VIAL
460.00
Rubilon 50mg
1
Rubilon VIAL
2100.00
Torrence 10mg
1
Torrence POWD
522.00
Torrence 50mg
1
Torrence POWD
2400.00
*All the prices in INR
You will hear from us only if the bid amount matches the minimum threshold and intended usage match our vision. You can resubmit another bid.